Tag: Gilead

Notizia

Business Consultant, Notizia, Oncology based Indications, Pharma Consultant

FDA gives thumbs-up to Balversa The U.S. FDA has granted approval of Balversa (erdafitinib) to Belgium-based Janssen Pharmaceutica, for the...

Read More

The Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Tetra, Shionogi sign USD 40 Million deal for Alzheimer’s disease and fragile X syndrome Tetra Discovery Partners is collaborating with...

Read More

Digital Pill: A new frontier in digital healthcare all set to take-off

Articles, Business Consultant, Pharma Consultant • One Comment

A digital pill is a tablet or capsule with embedded indigestible sensors that communicate about data outcomes related...

Read More

The Business Cocktail

Business Consultant, Oncology based Indications, PD-1 and PD-L1 inhibitors, Pharma Consultant, The Business Cocktail

AstraZeneca dragout Entasis files to fund antibiotic phase 3 for USD 86 Million IPO Massachusetts-based Entasis Therapeutics has spun out...

Read More

Notizia

Notizia

Gilead faces revived lawsuit claiming it sidestepped FDA with HIV drug imports Gilead Sciences thought it had prevailed in a whistleblower...

Read More

Hepatitis C drugs re-energize global fight over patents

Snippets

The liver disease hepatitis C is the new battleground for lawsuits intended to slash the cost of life-saving medicines. In February alone,...

Read More
Close